GeneNews Sees Uptick in Q3 Revenues; Cuts Net Loss by 64 Percent
November 11, 2009
GeneNews Sees Uptick in Q3 Revenues; Cuts Net Loss by 64 Percent
By a GenomeWeb staff reporter
The Canadian biomarker test developer attributed the revenue increase to a collaborative research agreement; an Asian biomedical consortium; and sales of its ColonSentry biomarker test.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.